Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Soken Chemical & Engineering Co.,Ltd., The Current Fiscal Year Ordinary Profit Revised Upward by 51%, Adds to Record High Profit Forecast
4972 Soken Chemical & Engineering Co.,Ltd. 【J-GAAP】
Earnings ReportSoken Chemical & Engineering Co.,Ltd. <4972> [TSE-S] announced its financial results after the market closed on November 5th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2025 (April to September) surged by 2.0 times that of the same period last year, reaching 3.63 billion yen.
In addition, the full-year consolidated ordinary profit has been revised upward by 51.2%, from the previous forecast of 4.1 billion yen to 6.2 billion yen (compared to 3.9 billion yen in the previous period), increasing the growth rate from 4.9% to 58.6%, further surpassing the previous forecast of record-high profits for two consecutive terms.
Based on the first-half performance announced by the company and the full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to grow by 20.5% from the same period last year, reaching 2.56 billion yen.
In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit increased by 67.8% from the same period last year, reaching 1.81 billion yen. The operating profit margin drastically improved from 10.0% in the same period last year to 16.2%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Sep, 2022 | 19,454 | 1,087 | 1,452 | 1,080 | 130.9 | 66.9 | Nov 4, 2022 | J-GAAP |
Apr - Sep, 2023 | 19,254 | 1,670 | 1,777 | 1,374 | 166.2 | 45.5 | Nov 6, 2023 | J-GAAP |
Apr - Sep, 2024 | 24,330 | 3,792 | 3,631 | 2,804 | 338.6 | 58.6 | Nov 5, 2024 | J-GAAP |
YoY | +26.4% | +127.1% | +104.3% | +104.1% | +103.7% |
First Half Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Sep, 2024 Guidance | 25,000 | 3,850 | 3,900 | 3,000 | 361.9 | 0 | Aug 5, 2024 | J-GAAP |
Apr - Sep, 2024 Results | 24,330 | 3,792 | 3,631 | 2,804 | 338.6 | 0 | Nov 5, 2024 | J-GAAP |
Revision Rate | -2.7% | -1.5% | -6.9% | -6.5% | -6.4% |
Guidance Update
Full Year Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Prev | 46,000 | 4,300 | 4,100 | 2,700 | 325.7 | 95 | May 15, 2024 | J-GAAP |
Mar, 2025 New | 47,500 | 6,500 | 6,200 | 4,100 | 494.6 | 95 | Nov 5, 2024 | J-GAAP |
Revision Rate | +3.3% | +51.2% | +51.2% | +51.9% | +51.9% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 22,064 | 2,158 | 2,132 | 1,255 | 151.7 | 95 | May 15, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 23,170 | 2,708 | 2,569 | 1,296 | 156.3 | 95 | Nov 5, 2024 | J-GAAP |
YoY | +5.0% | +25.5% | +20.5% | +3.3% | +3.1% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 38,129 | 2,034 | 2,169 | 1,436 | 173.9 | 85 | May 15, 2023 | J-GAAP |
Mar, 2024 | 41,318 | 3,828 | 3,909 | 2,629 | 317.7 | 95 | May 15, 2024 | J-GAAP |
Mar, 2025 Guidance | 47,500 | 6,500 | 6,200 | 4,100 | 494.6 | 95 | Nov 5, 2024 | J-GAAP |
YoY | +15.0% | +69.8% | +58.6% | +56.0% | +55.7% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jul - Sep, 2023 | 10,208 | 1,020 | 1,082 | 826 | 99.9 | 10.0 | Nov 6, 2023 | J-GAAP |
Oct - Dec, 2023 | 11,757 | 1,463 | 1,349 | 988 | 119.4 | 12.4 | Feb 5, 2024 | J-GAAP |
Jan - Mar, 2024 | 10,307 | 695 | 783 | 267 | 32.3 | 6.7 | May 15, 2024 | J-GAAP |
Apr - Jun, 2024 | 11,657 | 1,737 | 1,815 | 1,455 | 175.7 | 14.9 | Aug 5, 2024 | J-GAAP |
Jul - Sep, 2024 | 12,673 | 2,055 | 1,816 | 1,349 | 162.9 | 16.2 | Nov 5, 2024 | J-GAAP |
YoY | +24.1% | +101.5% | +67.8% | +63.3% | +63.0% |
Related Articles
Osaki Electric Co.,Ltd., First Half Ordinary Profit Decreases by 35%, July-September Ordinary Profit Decreases by 40%
Amazia,inc., Last Fiscal Year Net Income Loss Widened in Downward Revision, 31% Deficit Against Net Assets
DUSKIN CO.,LTD., The Current Fiscal Year Ordinary Profit Revised Downward by 24%, Dividend Revised down by 16 yen
TOWA PHARMACEUTICAL CO.,LTD., First Half Ordinary Profit Revised Upward to an Unexpected 1% Increase, Full Year also Increased
COMTURE CORPORATION, First Half Ordinary Profit Increases by 2%
GEOLIVE Group Corporation, First Half Ordinary Profit Decreases by 47%, July-September Ordinary Profit Decreases by 76%
I'rom Group Co.,Ltd., First Half Ordinary Profit Turns to Loss, July-September Ordinary Profit Turns to Loss
Kyushu Financial Group,Inc., The Current Fiscal Year Ordinary Profit Revised Upward to an Unexpected 8% Increase, Adds to Record High Profit, Dividend Revised Upward by 2 yen
ASKA Pharmaceutical Holdings Co.,Ltd., First Half Ordinary Profit Increases by 7%
T-Gaia Corporation, First Half Ordinary Profit Increases by 75%, July-September Ordinary Profit Increases by 33%